in class lecture note

34 views2 pages
31 Oct 2010
- biological and social lie of being born
- difference in where you are born
- improper ANC (neonatal care) of mother compromises
- maternal education contributes to knowledge to seek care (women have less education as
the goal of women is to find a good husband/family)
- habits of mother to child
- genetics is important contributor but difficult to modify/change survival
- maternal nutrition
- we are never at the same odds of surviving (programmed in our genes but also influenced
by the behaviour our families have, education, nutritional characteristics, and any
- every baby born has a heavy burden of risks that they do not have the choice of
- 41% of child births = neonatal
Æ will change depending on how developed regions are
- the more developed the area, the higher the share of neonatal deaths BECAUSE less deaths
in older ages than younger ages [boys are more fragile than girls - but also depending on
where you are born]
- families usually do not prefer girls - health affected
- of the world, only 40% of deaths are recorded [births were probably unregistered as well]
- uncertainty of the effects/patterns of death
- statistical arthritis -- do not have data, and the accessible data are too old
- measure real-time mortality trends
- improve coverage indicators
- mainstream equity in epidemiological research [where the action is happening]
- delivery channel research [only 10% of the global investment in health research is directed
at 90% of the global burden of the disease]
- how to make technology to evidence
- improve large-scale evaluation designs
- balance advocacy with evidence [to prove]
- inaccurate/outdated data -- overestimates and underestimates
- 2.3 million out of 9 million of child mortality in India
- WHO/UNICEF estimated 7000 of malarial deaths >5yo, but 50 000 in India
* if you have endless resources, it would be better to overestimate, but limited
resources and redirecting expenditures to tackle disease is harmful to the society
Æ challenges of large-scale evaluations
- vaccine trials may be unethical -- test medications that already work, only treat half of the
population but not the other
- efficacy-effectiveness gap
- in large countries, an average does not represent the country as vast range/spectrum of
Imbalances in health research
- problems and researchers are in different places
- 1090 gap, do not have enough people working in the public health sector
- DALY - # of years of life you lose due to a health condition
- global R&D investments per DALY
global average of all diseases = US$72 - funds in WRONG areas that do not
Unlock document

This preview shows half of the first page of the document.
Unlock all 2 pages and 3 million more documents.

Already have an account? Log in

Get OneClass Notes+

Unlimited access to class notes and textbook notes.

YearlyBest Value
75% OFF
$8 USD/m
$30 USD/m
You will be charged $96 USD upfront and auto renewed at the end of each cycle. You may cancel anytime under Payment Settings. For more information, see our Terms and Privacy.
Payments are encrypted using 256-bit SSL. Powered by Stripe.